Tin price bubble spells toil and trouble for global industry
Information you can trust Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia…
Exclusive: US FDA delays two drug reviews in new voucher program after safety, efficacy concerns
Reviews of Sanofi’s diabetes drug Tzield and Disc Medicine’s blood-disorder medicine bitopertin stalledTzield pushed back after adverse event…